Late treatment study
et al., medRxiv, doi:10.1101/2020.09.23.20199463 (Preprint)
Comparative Effectiveness of Famotidine in Hospitalized COVID-19 Patients
Retrospective database analysis focused on Famotidine but also showing results for HC
Q users, with unadjusted mortality RR 0.85, p
<0.001 (13.6% vs. 16.1%).
death, ↓15.4%, p<0.001
Please send us corrections, updates, or comments.